Its soft, bouncy texture hugs the skin like a second layer, delivering deep
By integrating biological, chemical, computational and clinical data into a continuously learning R&D engine, MAP is designed to make drug discovery and development more predictable, scalable and capital-efficient. MDR-001 is MindRanks lead candidate
Novel GLP-1 agonist dulaglutide wins AWARD for type 2 diabetes AT THE ADA ANNUAL SCIENTIFIC SESSIONS CHICAGO Dulaglutide, an investigational once-weekly long-acting glucagonlike peptide1 receptor agonist, provided superior glycemic control compared with sitagliptin in patients with type 2 diabetes in the phase III AWARD-5 trial
Store refrigerated at 2C-8C unless compound-specific requirements indicate otherwise
Castrejon JL, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, et al